Brind.
  1. Cellebrite DI Ltd. may benefit from Trump-era tariffs and onshoring trends, coinciding with Thomas E. Hogan's appointment as CEO.

Cellebrite announced that Tom Hogan has been replaced as CEO of the company.

1 report, 1 independent Updated Aug 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Cellebrite announced that Tom Hogan has been replaced as CEO of the company.

Who's involved

What this event is mainly about
CellebriteTom Hogan

Keep exploring

Part of

Cellebrite DI Ltd. may benefit from Trump-era tariffs and onshoring trends, coinciding with Thomas E. Hogan's appointment as CEO. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped